Halozyme (HALO): Q3 EPS of -$0.18 misses by $0.05. Revenue of $5.3M (-76.7% Y/Y) misses by...

|About: Halozyme Therapeutics, Inc. (HALO)|By:, SA News Editor
Halozyme (HALO): Q3 EPS of -$0.18 misses by $0.05. Revenue of $5.3M (-76.7% Y/Y) misses by $0.7M. Shares -1.4% AH. (PR)